Nathaniel Lipkus

Curb Your (Lobbying) Enthusiasm? Navigating Canada's Lobbying Regulations – Insights For The Pharmaceutical Industry

Winning Wellness: Strategic IP And Regulatory Considerations In Canada's Booming Natural Health Products Industry

U.K. Appellate Court Rules Artificial Neural Network Application Is Not Patent-Eligible Subject Matter

Can AI Be An Inventor On A Patent Or Author Of A Copyrighted Work?

PMPRB Releases Long-awaited Draft Guidelines Regarding Excessive Drug Pricing Under New Regime

Patty Patents: Canadian Courtroom Grilling In The Works?

Canadian Court Again Rejects Problem-solution Approach To Subject-matter Eligibility Of Computer-implemented Patents

The Impact Of CAR T Cell Patenting On Access To Therapy In Canada

Canadian Courts Are Interpreting Supplementary Pharmaceutical Patent Protection More Broadly Than Their EU Counterparts

Choueifaty Patent Application Found To Possess Patentable Subject-matter